Compare Danaher Corporation (DHR) vs Manchester United PLC (MANU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Manchester United PLC — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while Manchester United PLC trades at $20.51 (market cap $3.51B). The key difference: Danaher Corporation is far larger — about 43.6× Manchester United PLC's market cap, and Manchester United PLC pays the higher dividend (1.26%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Manchester United PLC for 109 Days on average.
| DHR | MANU | |
|---|---|---|
Market Cap | $152.87B | $3.51B |
Volume | 5,228,698 | 412,769 |
Sector | Health | Media |
52-Week High | $242.05 | $24.19 |
52-Week Low | $161.91 | $15.20 |
Typical Hold Time | 69 Days | 109 Days |
Enterprise Value | $175.08B | $4.33B |
Dividend Yield | 0.74% | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
Manchester United (MANU) trades at $20.32, up 0.35% with bearish technical signals despite recent earnings beats. The company shows mixed fundamentals with revenue growth to $666.51M in 2025 but persistent net losses (-$33.02M) and negative margins. Analyst sentiment is divided with 40% buy ratings while technical indicators show selling pressure outweighing buying signals 10-5.
The stock presents a valuation opportunity with P/S of 3.9x below sports franchise peers, but faces execution risks from consistent losses and high debt. Upside depends on Champions League revenue conversion while downside risks include ongoing profitability challenges in the competitive Premier League landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →
